NCT01482923

Brief Summary

"A treatment session especially for PLWHA to help them discuss and take action about their smoking may be useful."

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 22, 2011

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

November 28, 2011

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 1, 2011

Completed
7.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 21, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 21, 2019

Completed
Last Updated

November 4, 2019

Status Verified

November 1, 2019

Enrollment Period

7.9 years

First QC Date

November 28, 2011

Last Update Submit

November 1, 2019

Conditions

Keywords

Tobacco Use Assessmentsmoke tobaccoquit smokingtobacco cessationHIV/AIDSCommunity-Based Service Organizations11-173Low-Income Persons Living with HIV/AIDS

Outcome Measures

Primary Outcomes (1)

  • Feasibility of a motivational tobacco cessation intervention

    The study will test whether the percentage of eligible and enrolled study participants who complete the assigned intervention is significantly different from a population of percentages centered at 45%, i.e., the "null population percentage," considered a percentage too low to be compatible with feasibility."

    2 years

Secondary Outcomes (1)

  • Estimate the differences between the experimental intervention

    2 years

Study Arms (2)

Treatment As Usual (TAU)

This study is a pilot intervention trial examining the feasibility of a motivational smoking cessation intervention using respiratory biomarker feedback in low income PLWHA. The plan is to recruit a pilot sample of 50 eligible and consented participants, randomized at a 1:1 ratio into either the Treatment As Usual (TAU) condition or the experimental (Aspiration, Inspiration Respiration, or AIR) intervention condition.

Behavioral: Treatment as usual

Aspiration, Inspiration Respiration, or AIR

This study is a pilot intervention trial examining the feasibility of a motivational smoking cessation intervention using respiratory biomarker feedback in low income PLWHA. The plan is to recruit a pilot sample of 50 eligible and consented participants, randomized at a 1:1 ratio into either the Treatment As Usual (TAU) condition or the experimental (Aspiration, Inspiration Respiration, or AIR) intervention condition.

Behavioral: AIR (Aspirations, Inspiration, Respiration)

Interventions

Participants in the Treatment as Usual study arm will be provided with the following: 1) brief smoking cessation counseling as recommended in the Public Health Service treatment guidelines; 2) direct referral to the NY/NJ State Quitline; 3) a brochure that describes the Quitline services and provides contact information via telephone or internet; 4) a NY State brochure on HIV and smoking that identifies the specific risks of smoking for PLWHA; and 5) referral assistance to participants who present with untreated co-morbid conditions.

Treatment As Usual (TAU)

Participants in the Aspirations, Inspiration, and Respiration study arm will receive all of the components of Treatment as Usual along with these additional components: 1) a lung age test to determine the ability and functioning of their lungs; 2) a personal lung health report with their lung age, the CO level of their breath, and a summary of their respiratory symptom assessment; 3) a review of this personal lung health report with a study counselor, 4) motivational interviewing techniques guided by Self-Determination Theory concepts to explicitly elicit at least one life aspiration of the patient and encourage discussion of such aspirations using an autonomy-supportive approach.

Aspiration, Inspiration Respiration, or AIR

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

"Low-income smokers living with HIV/AIDS being served at community-based organizations."

You may qualify if:

  • Age 18 years or older as per self-report;
  • English speaking;
  • New York or New Jersey State resident;
  • HIV-positive serostatus direct referral from a CAB agency staff member, which verifies that the person is an HIV+ client, or by as verified by presentation of medical evidence (i.e.,confirmatory test result, ARV prescription, M11Q form, or lab results);
  • Self-report of smoking \> or = to 20 cigarettes (\> or = to one pack) within the prior 7 days;
  • To confirm smoking status, the carbon monoxide alveolar breath test must be \> or = to 10 ppm;
  • To confirm cognitive functioning, score on the in-person BLESSED Exam must be \< or = to 10;
  • Low income, defined by either: 1) Proof of Medicaid insurance, or 2) Self-report of income at 50% or below median income for New York State for New York State residents, or if a New Jersey resident, at or below 50% median income for New Jersey

You may not qualify if:

  • Presence of current severe psychopathology that would limit study participation (e.g., unstable schizophrenia, bipolar disorder recent changes to medication noncompliance);
  • Currently receiving smoking cessation treatment elsewhere.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

City College of New York

New York, New York, 10031, United States

Location

Related Links

MeSH Terms

Conditions

Tobacco Use CessationAcquired Immunodeficiency Syndrome

Interventions

TherapeuticsAirInhalationRespiration

Condition Hierarchy (Ancestors)

Health BehaviorBehaviorHIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Intervention Hierarchy (Ancestors)

AtmosphereEnvironmentEcological and Environmental PhenomenaBiological PhenomenaMeteorological ConceptsEnvironment and Public HealthRespiratory MechanicsRespiratory Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Study Officials

  • Jamie Ostroff, PhD

    Memorial Sloan Kettering Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 28, 2011

First Posted

December 1, 2011

Study Start

November 22, 2011

Primary Completion

October 21, 2019

Study Completion

October 21, 2019

Last Updated

November 4, 2019

Record last verified: 2019-11

Locations